FREE SHIPPING ON ORDERS OVER $150

glutathione tgf Kanglexin, a new anthraquinone compound, attenuates hepatic fibrosis by regulating the TGF-β/SMADS signaling pathway and metabolism Emerging targets in cancer drug

$20.06

Quantity
- +
Description

doi: 10.1007/s10875-012-9708-x 327 ChenKZengKJinSMaYCaiLXuPet al

glutathione tgf Kanglexin, a new anthraquinone compound, attenuates hepatic fibrosis by regulating the TGF-/SMADS signaling pathway and metabolism Emerging targets in cancer drug

Mol Biol Rep 48:28532861

glutathione tgf Kanglexin, a new anthraquinone compound, attenuates hepatic fibrosis by regulating the TGF-/SMADS signaling pathway and metabolism Emerging targets in cancer drug

15(6): 639656 Detection of Mycotoxins in Patients with Chronic Fatigue Syndrome

glutathione tgf Kanglexin, a new anthraquinone compound, attenuates hepatic fibrosis by regulating the TGF-/SMADS signaling pathway and metabolism Emerging targets in cancer drug

J., Samet, J

glutathione tgf Kanglexin, a new anthraquinone compound, attenuates hepatic fibrosis by regulating the TGF-/SMADS signaling pathway and metabolism Emerging targets in cancer drug

Tau, -synuclein, and FMRP undergo fibrillization via LLPS in AD (Pakravan et al., 2021

glutathione tgf Kanglexin, a new anthraquinone compound, attenuates hepatic fibrosis by regulating the TGF-/SMADS signaling pathway and metabolism Emerging targets in cancer drug

doi: 10.3389/fendo.2019.00896 70 FangLBaiCChenYDaiJXiangYJiXet al

glutathione tgf Kanglexin, a new anthraquinone compound, attenuates hepatic fibrosis by regulating the TGF-/SMADS signaling pathway and metabolism Emerging targets in cancer drug

You may also like

Frontiers

US$ 28.15

4.8 (24 reviews)

recommand products